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Concerns about the implantable cardioverter
defibrillator: A determinant of anxiety and depressive
symptoms independent of experienced shocks
Susanne S. Pedersen, PhD,a,b Ron T. van Domburg, PhD,b Dominic A. M. J. Theuns, MSc,b Luc Jordaens, MD, PhD,b
and Ruud A. M. Erdman, PhDb,c Tilburg and Rotterdam, The NetherlandsBackground Patients with an implantable cardioverter defibrillator (ICD) are at increased risk of anxiety disorders. In
turn, anxiety has been identified as a precipitant of ventricular arrhythmias. Anxiety may in part be attributed to concerns
about the ICD firing, but the relationship between ICD concerns, psychological morbidity, and shocks has not been
systematically investigated. We examined the relative importance of experienced shocks versus subjective concerns about the
ICD as determinants of anxiety and depressive symptoms in ICD patients.
Methods Consecutive surviving patients (n = 182, response rate = 82%) having had an ICD implanted between
October 1998 and January 2003 at the Erasmus Medical Centre Rotterdam were asked to fill in the ICD Patient Concerns
Questionnaire and the Hospital Anxiety and Depression Scale. Clinical variables were obtained from the patients’
medical records.
Results A total of 55 (30%) patients had received a shock from the ICD. Although patients who had experienced a shock
scored higher on ICD concerns, ICD concerns was the only independent determinant of anxiety (odds ratio 6.35, 95% CI
2.84-14.20) and depressive symptoms (odds ratio 2.29, 95% CI 1.06-4.96) adjusting for shocks and all other factors.
Conclusions Patient concerns about the ICD may be an important indicator of psychosocial adjustment. Screening for
ICD patient concerns using the ICD Patient Concerns Questionnaire may identify patients at risk for psychological morbidity
after ICD implantation. (Am Heart J 2005;149:664-9.)The implantable cardioverter defibrillator (ICD) was
initially developed to prolong survival and prevent
sudden cardiac death in patients with ventricular
arrhythmias. Indications for ICD therapy have since
expanded to include prophylactic treatment,1 as the
MADIT 1 and 2 and the MUSTT demonstrated that
prophylactic implantation improves survival in pa-
tient subgroups.2,3
Although the medical benefits of the ICD seem
unequivocal, ICD implantation may result in adverse
psychosocial outcome for particular subgroups of
patients as at least 30% manifest clinically significant
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doi:10.1016/j.ahj.2004.06.031this is equivalent to the prevalence in other cardiac
populations, some studies have reported higher levels of
distress in ICD patients.6,7 More importantly, anxiety
related to having an ICD may influence the risk of
arrhythmic events, as stress and anxiety have been
known for some time to be precipitants of arrhythmias.8
The association between mood and arrhythmias was also
recently demonstrated in 2 preliminary studies that
investigated the effects of anxiety and anger as precip-
itants.9,10 Implantable cardioverter defibrillator implan-
tation has also been shown to impact adversely on
quality of life (QoL),6,11 although a recent review
indicates that QoL may improve to preimplant levels at
1-year follow-up.5 Consensus as to how long the
adjustment period persists may not be achieved until
large-scale prospective studies of psychosocial outcome
in ICD patients are available.
However, ICD-related fears and concerns, in particu-
lar, fears about the ICD firing, are universal and have
been identified as a major determinant of psychological
distress, impaired QoL, and the extent to which patients
experience the ICD implantation as positive.5,6,11 The
ICD Patient Concerns (ICDC) Questionnaire is a brief
and standardized instrument that can be used to assess
these concerns and to identify ICD patients at risk for
Table I. Sociodemographic and clinical characteristics of the
patient responders (n = 182)
n (%) Mean (SD) Range
Women 35 (19)
Age 62 (13) 16-84
Married/partner 144 (79)
Education
University or equivalent 8 (4)
College 56 (31)
High school/A levels 64 (35)
Basic education
(up to grade 6)
47 (26)
Not known 7 (4)
Working 26 (14)
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relationship between ICD concerns, actual shocks
received, and anxiety and depressive symptoms has not
yet been investigated. A relationship between ICD
concerns and psychological morbidity would further
underscore the pivotal role of patient concerns with
reference to ICD-related health complaints and may
provide a specific target for intervention.
Therefore, the objectives of the current study were
(1) to examine the prevalence of patient concerns
about their ICD and (2) to evaluate the relative
importance of experienced shocks versus subjective

















1 Shock 14 (8)
N1 Shock 41 (23)
Inhospital arrest 30 (17)
Out-of-hospital arrest 75 (41)
*Based on data stored by the ICD.Methods
Patient selection
Patients (n = 225) having had an ICD implanted at the
Erasmus Medical Centre Rotterdam between October 1998 and
January 2003 were asked as part of routine clinical practice to
fill in a number of questionnaires to assess their psychological
health. Patients were excluded if they were terminally ill
(n = 1), had brain damage (n = 1), were younger than
16 years (n = 1), or had too many missing values on
questionnaires (n = 1). Of the remaining 221 patients, 182
(82% response rate) participated. No statistically significant
differences were found between responders and nonres-
ponders on sex and clinical variables ( P N .05), but
nonresponders were younger than responders (52 vs 62 years,
P b .001). Sociodemographic and clinical characteristics of
the patient responders are presented in Table I.
Measures
Variables assessed included sex, age, marital status, educa-
tion, and working status. Patients were also asked to indicate
whether they used psychotropic medication because of
stress, anxiety, depressive symptoms, or sleep disturbances.
Information on clinical variables (ie, etiology of coronary
artery disease, chronic heart failure, antiarrhythmic drug
therapy at baseline, time since implantation [in months],
number of shocks [appropriate and inappropriate] received
since implantation as read from the ICD, inhospital arrest,
and out-of-hospital arrest) was obtained from the patients’
medical records.
The ICDC Questionnaire was originally developed in British
ICD patients12 but was translated into Dutch according to
standard practice for the purpose of the current study. The
original ICDC Questionnaire consists of 20 items that are scored
on a 5-point Likert scale from 0 (not at all) to 4 (very much so).
The scale yields a score for number of concerns (range 0-20) and
a score for severity of concerns (range 0-80). A higher score on
both indicates a greater number of concerns and more severe
concerns. The scale is divided into 2 subscales, assessing
perceived limitations (eg, bDoing activities/hobbies that may
cause my ICD to fire Q ) and device-specific concerns (eg, bMy
ICD firing Q ). The psychometric properties of the ICDC Ques-
tionnaire are good with test-retest reliability (6 weeks) of 0.77
and Cronbach a of .94 for the total questionnaire.12The Hospital Anxiety and Depression Scale (HADS) was
included to assess psychological morbidity and to investigate
the discriminant validity of the ICDC Questionnaire.13 The
HADS assesses anxiety and depressive symptoms by means of
14 items that are answered on a 4-point Likert scale (0-3). The
score range for both the anxiety and depressive symptoms
subscales is 0 to 21. The HADS has been validated in somatic,
psychiatric, and cardiac patients and in the general population
and has been shown to be a valid and reliable instrument.14-17 A
cutoff score z8 for determining caseness on both subscales
was used in the current study, as this has been suggested to
yield an optimal balance between sensitivity and specificity.16
Statistical analyses
Principal components analysis (varimax rotation) was used
to examine the factor structure of the Dutch version of the
ICDC Questionnaire. A scree plot was used as criteria for
determining principal components to retain. Factor loadings
below 0.45 were suppressed. Cronbach a was calculated to
determine the internal consistency of subscales. Pearson
correlations were used to examine the discriminant validity of
the ICDC Questionnaire against the HADS. Discrete variables
were compared with the m2 test and are presented as
percentages. Continuous variables were compared with the
Student t test and are presented as mean values and SD. In the
case of multiple comparisons, we used analysis of variance
with a post hoc Bonferroni correction. Logistic univariate and
multivariate regression analyses were performed to examine
determinants of anxiety and depressive symptoms (using a
Table II. Frequency of endorsements, item means (SD), factor loadings, and internal consistency of the ICDC Questionnaire
Items of ICDC Questionnaire
Frequency of
endorsement in %* Mean (SD) Factor Iy
Internal
consistencyz
1. My ICD firing 64 1.19 (1.23) 0.63 .72
18. Getting too stressed in case my ICD fires 59 1.31 (1.42) 0.64 .72
13. Symptoms/pain associated with my ICD firing 58 1.27 (1.40) 0.62 .71
12. Having no warning my ICD will fire 51 96 (1.18) 0.59 .69
8. Time spent thinking about my ICD firing 48 0.82 (1.11) 0.62 .71
15. Not being able to prevent my ICD from firing 46 1.00 (1.34) 0.59 .69
10. Working too hard/overdoing things causing my ICD to fire 43 0.91 (1.27) 0.61 .70
5. Doing activities/hobbies that may cause my ICD to fire 36 0.72 (1.16) 0.55 .66































P < .001 
6.55 (6.99) 
11.89 (8.57) 
Mean (SD) ICD concerns stratified by shocks.
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marital status, time since ICD implantation, shocks, and ICD
concerns (with the upper tertile representing high levels of
concerns). Odds ratios (OR) with 95% CIs are reported for
univariate and multivariate analyses. All statistical tests used
were 2-tailed; P b .05 was used to indicate statistical
significance. All statistical analyses were performed using SPSS
11.5 (SPSS Inc, Chicago, Ill) for Windows.
Results
Patient concerns about their implantable
cardioverter defibrillator
Because the Dutch version of the ICDC Questionnaire
has not previously been used, we first subjected the
ICDC Questionnaire to a factor analysis and correlated it
with the HADS, a validated measure of anxiety and
depressive symptoms.
The Kaiser-Meyer-Olkin measure of sampling ade-
quacy (0.914) and Bartlett test of sphericity (b0.001)
indicated that it was appropriate to proceed with
factor analysis and that the correlation matrix was
suitable for further analysis. The scree plot suggested a
1-factor structure. On the basis of factor loadings, we
chose the 10 items that loaded the highest on the
unrotated component. These 10 items were subse-
quently subjected to a reliability analysis, which
showed that 2 items did not contribute significantly to
the overall variance. Hence, the final Dutch ICDC
Questionnaire consisted of 8 items explaining 61% of
the variance; all 8 items were related to concerns
about the ICD firing (Table II). The internal consis-
tency of the subscale was good with Cronbach a = .91
(Table II). Frequency of endorsements (score N0) on
the ICDC Questionnaire items ranged from 36% to
64% (Table II). The item with the highest endorse-
ment was bMy ICD firing Q with 64% of the patients
having this concern.
Implantable cardioverter defibrillator concerns as
measured by the ICDC Questionnaire correlatedpositively with anxiety (r = 0.61, P b .01) and
depressive symptoms (r = 0.42, P b .01) accounting
for 37% and 18% of the variance, respectively.
Although there is an overlap between ICD concerns
and anxiety and depressive symptoms, the unshared
variance of 63% and 82% indicates that the ICDC
Questionnaire and the HADS largely measure differ-
ent constructs.
Because the concerns that patients may have about
their ICD may be attributed to the number of shocks
they have received, we investigated the relationship
between shocks and ICD concerns. Shocks received
since implantation were related to ICD concerns; that is,
patients who had experienced 1 or more shocks
reported significantly more ICD-related concerns com-
Figure 3






























Mean (SD) depression score stratified by shocks and ICD concerns
Figure 2






















P = .001 
4.01 (3.51) 




Mean (SD) anxiety score stratified by shocks and ICD concerns.
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(Figure 1).
Shocks versus concerns as determinants of anxiety and
depressive symptoms
Of the 182 patients, 56 (32%) had anxiety, and 50
(28%) had depressive symptoms.
Patients with more ICD concerns were at higher risk
of anxiety (Figure 2) and depressive symptoms (Figure 3)
irrespective of whether they had experienced shocks.
Anxiety was attenuated in the no-shock/high ICD-
concern group compared with the shock/low ICD-
concern group ( P = .04), whereas no statistically
significant difference was found between these 2 groups
on depressive symptoms.
In univariate analyses, shocks (OR 2.58, 95% CI
1.32-5.03) and ICD concerns (OR 2.18, 95% CI 1.61-2.96)
were both associated with increased anxiety. Similarly,
ICD concerns were related to increased depressive
symptoms (OR 1.41, 95% CI 1.05-1.87). No other
variables were associated with anxiety and depressive
symptoms in univariate analyses.
In multivariate analyses, high levels of ICD con-
cerns (OR 6.35, 95% CI 2.84-14.20) remained an
independent determinant of anxiety adjusting for sex,
age, marital status, months since implantation, and
shocks. Implantable cardioverter defibrillator con-
cerns were also related to more depressive symp-




The results of the current study indicate that
patient ICD concerns are highly prevalent. Patient
concerns about the ICD were a determinant of
anxiety and depressive symptoms independent of
experienced shocks.
It is noteworthy that regardless of whether patients
had received shocks from the ICD, those scoring high
on ICD concerns had a higher mean score on both
anxiety and depressive symptoms. Implantable cardi-
overter defibrillator concerns were also associated with
a 6-fold increased risk of anxiety and a 2-fold increased
risk of depressive symptoms independent of shocks
and other factors. These findings suggest that ICD
concerns more so than shocks received from the ICD
may place patients at risk for psychopathology. Al-
though shocks have previously been shown to increase
the risk of psychological distress and adverse
QoL,11,18,19 the CIDS showed that there may be a dose-
response relationship between shocks and distress.19 In
the latter study, only patients who had received
z5 shocks were at risk of adverse outcome. In another
recent study of the current patient sample and their
partners, we found that the distressed personality—also
known as type D personality—was associated with
increased anxiety and depressive symptoms in both
ICD patients and their partners; this relationship
between personality and distress in patients remained
despite controlling for shocks.20 Taken together, these
findings suggest that we may need to expand our focus




668 Pedersen et alTime since ICD implantation could not explain
individual differences in anxiety and depressive symp-
toms. Although others have found that psychological
adaptation to the ICD improves over time,21 psychopa-
thology in ICD patients has also been found to be
unrelated to time since implantation.22 This finding
indicates that if concerns are not dealt with early on,
they are likely to persist over time. In fact, addressing
concerns about the ICD as early as preimplantation may
be necessary to reduce psychological morbidity, to
enhance QoL, and to reduce the risk of arrhythmic
events because emotional states have been shown not
only to impact adversely on QoL6,11 but also to
precipitate arrhythmic events.9
We found that ICD concerns can best be measured by
an 8-item version of the ICDC Questionnaire because
this shortened version accounted for slightly more
variance (61% vs 57%) than the original 20-item
version.12 Moreover, the 8-item version was as psycho-
metrically sound as the original 20-item version.12 This
makes it a more optimal instrument to use in clinical
practice and in research settings because it poses less of
a burden to patients.
The results of the current study should be interpreted
with caution, in particular, because of the cross-sectional
design of the study. The nature of the design does not
allow for the determination of cause and effect and also
provides no information about fluctuations over time in
concerns and psychological morbidity. We also had no
information about previous psychiatric history and the
use of psychotropic medication before implantation.
Previous psychiatric history is a known predictor of
future psychopathology. In addition, we could not make
a distinction between appropriate and inappropriate
shocks. Inappropriate shocks have been associated with
more psychological distress, but this finding was based
on only 25 patients, and the determination of appropri-
ateness was based on the patient’s subjective interpre-
tation.23 Although the results are preliminary and should
be replicated in prospective studies, in particular, to
further disentangle the relationship between anxiety,
depressive symptoms, shocks, and ICD concerns, the
ICDC Questionnaire seems to be a promising instrument
that may be used in clinical practice to identify patients
at risk for adverse outcome.
In conclusion, we found that ICD concerns were
associated with an increased risk of anxiety and
depressive symptoms irrespective of shocks. This
finding suggests that we may need to expand our view
of indicators of psychosocial adjustment in ICD
patients. Large-scale prospective studies that include
preimplantation and postimplantation assessments are
now warranted to examine the relationship between
shocks, concerns, and psychological morbidity. Such
studies would shed further light on the role of
psychological factors as precipitants of arrhythmias.The brevity and reliability of the 8-item ICDC Ques-
tionnaire make it suitable to use as a research tool and
in clinical practice to identify patients at risk who may
benefit from psychosocial intervention. Psychosocial
interventions targeting the concerns that patients may
have about their ICD are also required given our
findings that concerns were a determinant of psycho-
logical morbidity independent of shocks. The recent
preliminary results of a randomized controlled trial of
comprehensive cardiac rehabilitation in ICD patients
indicate that such a program is safe and leads to an
improvement in exercise ability and a reduction in
psychological distress.24
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